High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Charalampia Kyriakou(The Royal Free Hospital), Norbert Schmitz(University Hospital Münster), Bernd Metzner(Klinikum Oldenburg), Niklas Theorin(University Medical Center Freiburg), Jürgen Finke(University Medical Center Freiburg), Hans‐Jochem Kolb(Deutsche Klinik für Diagnostik), Carmen Canals(Hospital de Sant Pau), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Gunnar Öberg(Karolinska University Hospital), Ann Hunter(University Medical Center Freiburg), Peter Reimer(Essen University Hospital), Joachim Kienast(University of Münster), Anthony P. Goldstone(Hammersmith Hospital), Dolores Caballero(Complejo Hospitalario de Salamanca), Guido Kobbe(Düsseldorf University Hospital)
Cited by 155
Related Papers
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
|Blood|1998|2.6k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k